OleanderPhoenix Biotechnology executes a fourth amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center. Posted on April 2010June 2022 by Carlos Torres 06 Apr Society of Integrative Oncology (SIO) International Conference- comprehensive poster presentation with discussion. Publication: Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunits.
